封面
市場調查報告書
商品編碼
1935186

按產品類型、技術、應用和地區分類的生物分解支架市場

Biodegradable Scaffold Market, By Product Type, By Technology, By Application, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,可生物分解支架市場價值將達到 5.2 億美元,到 2033 年將達到 11.65 億美元,2026 年至 2033 年的複合年成長率為 12.2%。

報告覆蓋範圍 報告詳情
基準年: 2025 2026年市場規模: 5.2億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
預測期(2026-2033年)複合年成長率: 12.20% 2033 年的預測值: 11.65億美元

隨著研究人員不斷革新遞送方式、提升材料品質並拓展潛在醫療應用,可生物分解支架市場正在發生顯著變化。組織工程、3D生物列印和聚合物科學領域的策略性進步在影響這些市場動態發揮關鍵作用。可生物分解支架通常由天然或合成聚合物構成,是骨再生、創傷治療、心血管修復和牙科應用等快速發展領域的重要工具。

在結構設計中應用3D生物列印和先進奈米技術,可提高生物可分解支架的性能效率和穩定性。採用靜電紡絲、個人化醫療和電腦輔助設計的現代化製造系統,能夠促進細胞生長,提高手術成功率,並提升臨床安全標準。這種轉變為能夠以低成本提供具有特定分解速率的高純度生物可吸收材料的製造商創造了競爭優勢。這些創新結構使醫生能夠透過提供臨時支撐來治療複雜的組織損傷,這些支撐在癒合後可被人體安全吸收。

市場動態

生物可分解支架市場正顯著擴張,這主要歸功於其在組織工程領域的重要角色。這些生物材料模板為新組織形成提供必要的支撐,降低長期植入排斥的風險,並促進有效的自然癒合。生物可分解支架在再生醫學和臨床產品中的應用日益廣泛,這主要得益於其作為臨時基質和生長調節劑的有效性,從而顯著推動了市場需求。這些生物可吸收支架無需術後移除,即可促進受損表面的骨骼和皮膚再生,從而改善手術癒合。

此外,對高效創傷護理流程日益成長的需求是推動生物可分解支架市場成長的主要動力,因為它們在各種整形外科、牙科和心臟應用中發揮著至關重要的組織修復和調理作用。這些聚合物支架被廣泛用於調節細胞環境,促進骨骼中鈣等天然礦物質的形成,並促進組織重塑過程,從而改善患者的生活品質。藥物傳遞、整形外科和腫瘤學等行業高度依賴工程組織,而工程組織需要生物可分解支架等材料來確保運作效率並符合安全標準。

全球對個人化和安全植入的需求日益成長,顯著推動了可生物分解支架市場的發展,這主要歸功於其在再生醫學領域的廣泛應用。這些可生物分解支架透過促進細胞增殖和蛋白質離子沉積來支撐組織,從而促進器官修復。這項特性不僅在大規模醫院的外科部門至關重要,在專業研究系統中也同樣重要,因為材料的品質直接影響修復效率和是否符合醫療法規。

本次調查的主要特點

  • 本報告對可生物分解支架市場進行了詳細分析,以 2025 年為基準年,給出了預測期(2026-2033 年)內的市場規模和複合年成長率。
  • 我們將重點介紹各個細分市場的潛在商機,並說明該市場具有吸引力的投資提案矩陣。
  • 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 根據以下參數對生物分解支架市場的主要企業進行了分析:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 生物分解支架市場報告涵蓋了該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過各種用於分析生物分解支架市場的策略矩陣輕鬆做出決策。

目錄

第1章 研究目標與前提條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場範圍

  • 報告概述
    • 市場定義和範圍
  • 執行摘要

第3章 市場動態、監管與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 法規環境
  • 產品上市及核准情況
  • PEST分析
  • 波特分析
  • 市場機遇
  • 法規環境
  • 重大進展
  • 產業趨勢

4. 2020-2033年全球可生物分解支架市場(依產品類型分類)

  • 水凝膠
  • 聚合物支架
  • 基於奈米纖維的支架
  • 微圖案化表面微孔盤

5. 2020-2033年全球可生物分解支架市場(依技術分類)

  • 去細胞技術
  • 合成支架
  • 3D列印
  • 其他

6. 2020-2033年全球可生物分解支架市場(依應用領域分類)

  • 神經病學
  • 泌尿系統
  • 整形外科
  • 牙科
  • 心血管系統
  • 癌症
  • 皮膚/塗層
  • 胃腸病學/婦科
  • 其他

7. 2020-2033年全球可生物分解支架市場(按地區分類)

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 亞太其他地區
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第8章 競爭情勢

  • Merck KGaA
  • 3D Biotek LLC
  • Medtronic
  • Xanofi
  • Akron Biotech
  • Nanofiber Solutions
  • Vericel Corporation
  • NuVasive, Inc.
  • Organogenesis, Inc.
  • Biostage, Inc.
  • In2Bones Global
  • Orthofix Medical Inc.
  • Spine Smith
  • Invivo Therapeutics Holdings Corp.
  • Onkos Surgical

第9章 分析師建議

  • 機會
  • 分析師觀點
  • Coherent Opportunity Map

第10章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI4734

Biodegradable Scaffold Market is estimated to be valued at USD 520 Mn in 2026 and is expected to reach USD 1,165 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.2% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 520 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 12.20% 2033 Value Projection: USD 1,165 Mn

The biodegradable scaffold market is evolving significantly as researchers reshape delivery methods, improve material quality, and broaden medical use possibilities. Strategic advancements in tissue engineering, 3D bioprinting, and polymer science play a critical role in influencing these market dynamics. Biodegradable scaffolds, which are typically composed of natural or synthetic polymers, are essential tools utilized in rapidly advancing fields such as bone regeneration, wound healing, cardiovascular repair, and dental applications.

The use of 3D bioprinting and advanced nanotechnology in structural design enhances the efficiency and consistency of biodegradable scaffold performance. Modern manufacturing systems employing electrospinning, personalized medicine, and computer-aided design lead to better cell growth, higher surgical success rates, and improved clinical safety standards. This shift creates a competitive edge for producers who supply high-purity, bioresorbable materials with specific degradation rates at lower production costs. These innovative structures allow doctors to treat complex tissue injuries by providing a temporary support that the body safely absorbs after healing.

Market Dynamics

The market for biodegradable scaffolds is expanding significantly, primarily due to their critical role in the tissue engineering sector. These biomaterial templates serve as essential support agents in the creation of new tissue. They reduce the risk of long-term implant rejection and facilitate effective natural healing. The increasing biodegradable scaffolds in regenerative medicine and clinical products are substantially propelling the demand within the market due to their efficacy as a temporary matrix and growth regulator. These bioresorbable frameworks improve the healing power of surgeries by neutralizing the need for follow-up removals and enabling better regrowth of bone and skin across damaged surfaces.

Furthermore, the rising demand for effective wound care processes is significantly propelling the growth of the biodegradable scaffold market, owing to its crucial role in repairing and conditioning tissue for various orthopedic, dental, and cardiac applications. These polymeric supports are widely used to adjust the environment of cells, precipitate the formation of natural minerals like calcium in bones, and facilitate remodeling processes that improve patient quality. Industries such as drug delivery, plastic surgery, and oncology heavily rely on engineered tissue, which often necessitates materials like biodegradable scaffolds to ensure operational efficiency and meet safety standards.

The increasing global demand for personalized and safe implants is significantly contributing to the growth of the biodegradable scaffold market, mainly because of its extensive use in regenerative therapy processes. These bio-scaffolds are extensively used to support tissue by precipitating cell growth and protein ions, which are responsible for organ recovery. This function is critical not only in large hospital surgical units but also in specialized research systems, where the quality of the material directly impacts recovery efficiency and compliance with healthcare regulations.

Key Features of the Study

  • This report provides in-depth analysis of the biodegradable scaffold market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the biodegradable scaffold market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Merck KGaA, 3D Biotek LLC, Medtronic, Xanofi, Akron Biotech, Nanofiber Solutions, Vericel Corporation, NuVasive, Inc., Organogenesis, Inc., Biostage, Inc., In2Bones Global, Orthofix Medical Inc., Spine Smith, Invivo Therapeutics Holdings Corp., and Onkos Surgical
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The biodegradable scaffold market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Biodegradable scaffold market

Market Segmentation

  • Product Type Insights (Revenue, USD Mn, 2020 - 2033)
    • Hydrogels
    • Polymeric Scaffolds
    • Nanofiber Based Scaffolds
    • Micropatterned Surface Microplates
  • Technology Insights (Revenue, USD Mn, 2020 - 2033)
    • Decellularized Technology
    • Synthetic Scaffold
    • 3D Printing
    • Others
  • Application Insights (Revenue, USD Mn, 2020 - 2033)
    • Neurology
    • Urology
    • Orthopedics
    • Dental
    • Cardiology & Vascular
    • Cancer
    • Skin & Integumentary
    • Gastroenterology & Gynecology
    • Others
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
  • Key Players Insights
    • Merck KGaA
    • 3D Biotek LLC
    • Medtronic
    • Xanofi
    • Akron Biotech
    • Nanofiber Solutions
    • Vericel Corporation
    • NuVasive, Inc.
    • Organogenesis, Inc.
    • Biostage, Inc.
    • In2Bones Global
    • Orthofix Medical Inc.
    • Spine Smith
    • Invivo Therapeutics Holdings Corp.
    • Onkos Surgical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Biodegradable Scaffold Market, By Product Type
    • Global Biodegradable Scaffold Market, By Technology
    • Global Biodegradable Scaffold Market, By Application
    • Global Biodegradable Scaffold Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trend

4. Global Biodegradable Scaffold Market, By Product Type, 2020-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hydrogels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Polymeric Scaffolds
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Nanofiber Based Scaffolds
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Micropatterned Surface Microplates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

5. Global Biodegradable Scaffold Market, By Technology, 2020-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Decellularized Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Synthetic Scaffold
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • 3D Printing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

6. Global Biodegradable Scaffold Market, By Application, 2020-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Urology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Orthopedics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Cardiology & Vascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Skin & Integumentary
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Gastroenterology & Gynecology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

7. Global Biodegradable Scaffold Market, By Region, 2020 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • 3D Biotek LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Xanofi
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Akron Biotech
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nanofiber Solutions
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vericel Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • NuVasive, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Organogenesis, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biostage, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • In2Bones Global
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Orthofix Medical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Spine Smith
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Invivo Therapeutics Holdings Corp.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Onkos Surgical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us